Equine hEGF antibody and antigen (recombinant protein)
Diagnostic anti-Equine hEGF antibodies pairs and antigen for animal health (animal Equine/Horse lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-hEGF-Ag01 | Recombinant Equine hEGF protein | 3090 |
GMP-EQU-hEGF-Ab01 | Anti-Equine hEGF mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-hEGF-Ab02 | Anti-Equine hEGF mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-hEGF-Ab03 | Anti-Equine hEGF human monoclonal antibody (mAb) | 1953 |
GMP-EQU-hEGF-Ab04 | Anti-Equine hEGF human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-hEGF-Ag01 |
Product Name | Recombinant Equine hEGF protein |
Target/Biomarker | Equine epidermal growth factor (hEGF) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine epidermal growth factor antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck. |
Tag | His |
Products description | Recombinant Equine hEGF protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-hEGF-Ab01, GMP-EQU-hEGF-Ab02 |
Product Name | Anti-Equine hEGF mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine epidermal growth factor (hEGF) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine epidermal growth factor antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-hEGF antibodies in hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck. |
Tag | mFc |
Products description | Anti-Equine hEGF mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-hEGF antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-hEGF-Ab03, GMP-EQU-hEGF-Ab04 |
Product Name | Anti-Equine hEGF human monoclonal antibody (mAb) |
Target/Biomarker | Equine epidermal growth factor (hEGF) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine epidermal growth factor antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-hEGF antibodies in hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck. |
Tag | hFc |
Products description | Anti-Equine hEGF human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-hEGF antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Human Epidermal Growth Factor (hEGF) is a protein with profound implications in cell biology and tissue regeneration. Although its origin is human, EGF-related molecules and signaling pathways have also been identified in horses (equines), albeit with structural differences. EGF is a member of the epidermal growth factor family, a group of proteins known for their pivotal roles in regulating cell growth, proliferation, and tissue repair. The principal receptor for EGF is the Epidermal Growth Factor Receptor (EGFR), which is present on the surface of various cell types. Upon binding to EGFR, EGF initiates a cascade of intracellular events that stimulate cell division, tissue repair, and the maintenance of healthy epithelial tissues. In horses, EGF-like molecules and their associated signaling pathways exhibit functional similarities to their human counterparts. While the specific structure of EGF in horses may not be identical to that in humans, the fundamental principles of EGF-mediated cellular responses are conserved. This implies that EGF pathways play essential roles in equine physiology, contributing to tissue homeostasis, repair, and regeneration.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.